Leidos Holdings earnings release, August 4, 2026

Leidos Holdings, Inc. (LDOS) · Form 8-K, Item 2.02 · Filed · SEC filing

Leidos Delivers Strong Second Quarter and Enhances Full-Year Guidance u

Revenues of $4.6 billion, up 7% year-over-year u

Net income of $356 million or $2.81 per diluted share u

Adjusted EBITDA (non-GAAP) of $631 million and Adjusted EBITDA margin (non-GAAP) of 13.8% u

Non-GAAP Diluted Earnings per Share of $3.26, up 2% year-over-year u

Cash Flows from Operations of $793 million; Non-GAAP Free Cash Flow of $761 million

RESTON, Va., August 4, 2026 – Leidos Holdings, Inc. (NYSE: LDOS) today reported financial results for the second quarter of fiscal year 2026, highlighted by robust revenue growth and free cash flow generation.

"I'm pleased to report another strong quarter for Leidos," said Chief Executive Officer Tom Bell. "In addition to achieving milestones for revenue and cash, we booked $5 billion of contract awards. We’re seeing meaningful growth emerge across our Defense Tech, Energy Infrastructure, and Cyber growth pillars. And we have greater visibility into the long-term role of our Managed Healthcare pillar. The strength of our balanced portfolio allows us to enhance our 2026 guidance for revenues, earnings, and cash.”

SUMMARY OPERATING RESULTS

Revenues for the quarter were $4.56 billion, up 7% compared to the second quarter of 2025, including 4% organically. Revenues grew year-over-year due to increased customer demand for defense tech products, energy and air traffic management solutions, and intelligence mission support.

For the second quarter, net income was $356 million, or $2.81 per diluted share. Net income and diluted EPS were both down 9% and 7%, respectively, year-over-year; net income margin was 7.8% compared to 9.2% in the second quarter of 2025. Net income and diluted EPS for the quarter reflect $29 million in costs associated with the acquisition of ENTRUST Solutions Group ("Entrust") and the pending joint venture with Analogic Corporation, as well as restructuring costs associated with the NorthStar 2030 re-alignment. Adjusting for these and certain other items, non-GAAP net income decreased 1% year-over-year, to $413 million for the second quarter, and non-GAAP diluted EPS increased 2% to $3.26.

In addition, adjusted EBITDA was $631 million for the second quarter, down 2% year-over-year. Adjusted EBITDA margin of 13.8% decreased from 15.2% in the second quarter of 2025. Profitability in the current quarter reflected excellent program execution and disciplined cost management across the portfolio; profitability in the year-ago quarter benefited from several one-time, non-operational gains, including a $25 million insurance reimbursement for legal costs.

CASH FLOW SUMMARY

Net cash provided by operating activities for the quarter was $793 million for an operating cash flow conversion ratio of 224%. After adjusting for property, equipment, and software payments, quarterly free cash was $761 million for a free cash flow conversion ratio of 185%.

For the quarter, Leidos used $38 million in investing activities, including $32 million in property, equipment and software payments. Leidos used $423 million in financing activities, consisting primarily of $300 million in debt paydown and $127 million returned to shareholders, including $72 million in share repurchases and $55 million as part of a regular quarterly cash dividend program. As of July 3, 2026, Leidos had $748 million in cash and cash equivalents and $6.0 billion of debt.

NEW BUSINESS AWARDS

Net bookings totaled $4.9 billion in the quarter, representing a book-to-bill ratio of 1.1. As a result, backlog at the end of the quarter was $48.7 billion, of which $10.2 billion was funded. Trailing-twelve-month book-to-bill of 1.1 resulted in year-over-year growth in total and funded backlog of 5% and 44%, respectively. Quarterly bookings included several key awards: u

Avionics Intermediate Shop (AIS) Production Support Integration (PIS).

The U.S. Air Force Sustainment Center awarded Leidos a $475 million follow-on AIS PIS contract to manage the computerized diagnostic system that fixes the F-16 fighter jets. The company will deliver independent systems engineering, resolve complex component shortages, and manage original equipment manufacturer subcontracts. This work ensures sustained mission readiness of F-16 fleets for the U.S. Air Force, European, and foreign partners. u

General Services Administration (GSA) Military OneSource.

Leidos secured a $456 million contract from the GSA to manage the Military OneSource program over the next four years. Under this agreement, Leidos will deliver comprehensive 24/7 well-being services, including confidential counseling, tax support, and relocation tools to more than 4.7 million service members and their families worldwide. This strategic win further cements Leidos as a leading provider of global military health and managed health services. u

U.S. Air Force Electronic Warfare Mission Support.

Leidos received a $350 million contract modification to provide additional high-end technical support for the U.S. Air Force Material Command. The company will supply additional units of its advanced low-band surveillance radar infrastructure alongside specialized signal-processing software. These mission-critical capabilities are engineered to defeat adversary low-observable assets and mitigate heavy electronic countermeasures, providing defense networks with the definitive, high-fidelity threat intelligence required for modern multi-domain operations. u

Defense Health Agency (DHA) Reserve Health Readiness Program (RHRP) 3.1.

Leidos will maintain uninterrupted medical and dental exams for U.S. military reservists under a potential 30-month, $325 million contract modification while the DHA finalizes its long-term transition strategy for RHRP. u

Customs Border Patrol (CBP) Medium Energy Mobile (MEM) Systems.... (truncated)exible, non-intrusive inspection units scan vehicles and cargo for contraband, drugs, and weapons and will be deployed at various points of entry across the U.S. This award will align to the Leidos Security Enterprise Solutions and Analogic Corporation joint venture upon its formation. u

Naval Surface Warfare Center (NSWC) Multi-Service Advanced Capability Hypersonics Test Bed (MACH-TB) 2.0.

The NSWC awarded Leidos an $88 million other transaction authority (OTA) contract to develop experimental hypersonic glide vehicles to serve as real-world testbeds for advancing high-speed flight technologies.

FORWARD GUIDANCE

Leidos is raising its fiscal year 2026 guidance as follows:

For information regarding adjusted EBITDA margin and non-GAAP diluted EPS, see the related explanations and reconciliations to GAAP measures included elsewhere in this release.

Leidos does not provide a reconciliation of forward-looking adjusted EBITDA margins or non-GAAP diluted EPS to net income margin or diluted EPS due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. Because certain deductions for non-GAAP exclusions used to calculate projected net income margin or diluted EPS may vary significantly based on actual events, Leidos is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income at this time. The amounts of these deductions may be material and, therefore, could result in projected net income margin and diluted EPS being materially less than what may be implied by projected adjusted EBITDA margins and non-GAAP diluted EPS.

CONFERENCE CALL INFORMATION

Leidos management will discuss operations and financial results in an earnings conference call beginning at 8 A.M. eastern time on August 4, 2026. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Leidos Investor Relations website ( http://ir.leidos.com).

An archived version of the webcast will be available on the Leidos Investor Relations website until August 4, 2027.

ABOUT LEIDOS

Leidos is an industry and technology leader serving government and commercial customers with smarter, more efficient digital and mission innovations. Headquartered in Reston, Virginia, with 50,000 global employees, Leidos reported annual revenues of approximately $17.2 billion for the fiscal year ended January 2, 2026. For more information, visit www.leidos.com.

Financial statements

Income Statement

Three Months Ended — SUMMARY OPERATING RESULTS (in millions, except margin and per share data)

Three Months Ended – July 3, 2026Three Months Ended – July 4, 2025
Revenues4,5584,253
Net income356393
Net income margin7.8%9.2%
Diluted earnings per share (EPS)2.813.01
Non-GAAP Measures*:Adjusted EBITDA631647
Non-GAAP Measures*:Adjusted EBITDA margin13.8%15.2%
Non-GAAP Measures*:Non-GAAP diluted EPS3.263.21
Non-GAAP Measures*:* Non-GAAP financial measures should be considered in addition to, but not as a substitute for, the information provided in accordance with GAAP. Management believes that these non-GAAP measures provide another representation of Leidos' results of operations and financial condition, including its ability to comply with financial covenants. See Non-GAAP Financial Measures at the end of this press release for more information and a reconciliation of our selected reported results to these non-GAAP measures.* Non-GAAP financial measures should be considered in addition to, but not as a substitute for, the information provided in accordance with GAAP. Management believes that these non-GAAP measures provide another representation of Leidos' results of operations and financial condition, including its ability to comply with financial covenants. See Non-GAAP Financial Measures at the end of this press release for more information and a reconciliation of our selected reported results to these non-GAAP measures.* Non-GAAP financial measures should be considered in addition to, but not as a substitute for, the information provided in accordance with GAAP. Management believes that these non-GAAP measures provide another representation of Leidos' results of operations and financial condition, including its ability to comply with financial covenants. See Non-GAAP Financial Measures at the end of this press release for more information and a reconciliation of our selected reported results to these non-GAAP measures.

Income Statement

Leidos is raising its fiscal year 2026 guidance as follows:

FY26 Guidance – CurrentFY26 Guidance – Prior
Revenues (B)$18.20 - $18.40$18.00 - $18.40
Adjusted EBITDA MarginMid 13%Mid 13%
Non-GAAP Diluted EPS$12.20 - $12.50$12.10 - $12.50
Cash Flows Provided by Operating Activities (B)Approximately $1.85Approximately $1.80

Income Statement

Three Months Ended — UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in millions, except per share data)

Three Months Ended – July 3, 2026Three Months Ended – July 4, 2025Six Months Ended – July 3, 2026Six Months Ended – July 4, 2025
Revenues4,5584,2538,9588,498
Cost of revenues3,7413,4717,3806,959
Selling, general and administrative expenses283217506447
Acquisition, integration and restructuring costs272626
Equity earnings of non-consolidated subsidiaries-7-8-12-15
Operating income5145711,0221,101
Non-operating expense:Interest expense, net-69-55-124-104
Non-operating expense:Other income (expense), net62-18-1
Non-operating expense:Income before income taxes451518880996
Non-operating expense:Income tax expense-95-125-189-238
Non-operating expense:Net income356393691758
Non-operating expense:Less: net income attributable to non-controlling interest2294
Non-operating expense:Net income attributable to Leidos common stockholders354391682754
Earnings per share:Basic2.813.035.415.84
Earnings per share:Diluted2.813.015.375.8
Weighted average number of common shares outstanding:Basic126129126129
Weighted average number of common shares outstanding:Diluted126130127130
Weighted average number of common shares outstanding:Cash dividends declared per share0.430.40.860.8

Income Statement

Three Months Ended — UNAUDITED SEGMENT OPERATING RESULTS (in millions)

Three Months Ended – July 3, 2026Three Months Ended – July 4, 2025Six Months Ended – July 3, 2026Six Months Ended – July 4, 2025
Intelligence & Digital1,4991,4083,0122,816
Health1,0861,1752,2742,363
Homeland1,0187711,8341,541
Defense9558991,8381,778
Total4,5584,2538,9588,498
Operating income (loss):Intelligence & Digital142135288267
Operating income (loss):Health254303538591
Operating income (loss):Homeland9264125125
Operating income (loss):Defense8478146152
Operating income (loss):Corporate-58-9-75-34
Operating income (loss):Total5145711,0221,101
Operating income margin:Intelligence & Digital9.59.69.69.5
Operating income margin:Health23.425.823.725
Operating income margin:Homeland98.36.88.1
Operating income margin:Defense8.88.77.98.5
Operating income margin:Total11.313.411.413

Income Statement

Three Months Ended July 3, 2026 — ended July 3, 2026:

Three Months Ended July 3, 2026 – As reportedThree Months Ended July 3, 2026 – Acquisition, integration and restructuring costs (1)Three Months Ended July 3, 2026 – Amortization of acquired intangiblesAsset impairment chargesNon-GAAP results
Operating income51429401584
Non-operating expense, net-63-63
Income before income taxes45129401521
Income tax expense(2)-95-3-10-108
Net income35626301413
Less: net income attributable to non-controlling interest22
Net income attributable to Leidos common stockholders35426301411
Diluted EPS attributable to Leidos common stockholders(3)2.810.210.240.013.26
Diluted shares126126126126126

Income Statement

Three Months Ended July 4, 2025 — ended July 4, 2025:

Three Months Ended July 4, 2025 – As reportedThree Months Ended July 4, 2025 – Acquisition, integration and restructuring costsThree Months Ended July 4, 2025 – Amortization of acquired intangiblesNon-GAAP results
Operating income571232605
Non-operating expense, net-53-53
Income before income taxes518232552
Income tax expense(1)-125-1-7-133
Net income393125419
Less: net income attributable to non-controlling interest22
Net income attributable to Leidos common stockholders391125417
Diluted EPS attributable to Leidos common stockholders(2)3.010.010.193.21
Diluted shares130130130130

Income Statement

Three Months Ended July 4, 2025 — ended July 4, 2025:

Three Months Ended July 4, 2025 – As reportedThree Months Ended July 4, 2025 – Acquisition, integration and restructuring costsThree Months Ended July 4, 2025 – Amortization of acquired intangiblesNon-GAAP results
Net income393125419
Income tax expense(1)12517133
Income before income taxes518232552
Depreciation expense4040
Amortization of intangibles32-32
Interest expense, net5555
Adjusted EBITDA6452647
Adjusted EBITDA margin15.215.2

Income Statement

Six Months Ended July 3, 2026

Six Months Ended July 3, 2026 – As reportedSix Months Ended July 3, 2026 – Acquisition, integration and restructuring costs(1)Six Months Ended July 3, 2026 – Amortization of acquired intangiblesSix Months Ended July 3, 2026 – Asset impairment chargesSix Months Ended July 3, 2026 – Settlement loss on pension plan buy-outSix Months Ended July 3, 2026 – Acquisition related financing costsSix Months Ended July 3, 2026 – Non-GAAP results
Operating income1,022647011,157
Non-operating expense, net-142235-114
Income before income taxes880647012351,043
Income tax expense(2)-189-9-17-6-1-222
Net income69155531174821
Less: net income attributable to non-controlling interest99
Net income attributable to Leidos common stockholders68255531174812
Diluted EPS attributable to Leidos common stockholders(3)5.370.430.420.010.130.036.39
Diluted shares127127127127127127127

Income Statement

Six Months Ended July 3, 2026

Six Months Ended July 3, 2026 – As reportedSix Months Ended July 3, 2026 – Acquisition, integration and restructuring costs(1)Six Months Ended July 3, 2026 – Amortization of acquired intangiblesSix Months Ended July 3, 2026 – Asset impairment chargesSix Months Ended July 3, 2026 – Settlement loss on pension plan buy-outSix Months Ended July 3, 2026 – Acquisition related financing costsSix Months Ended July 3, 2026 – Non-GAAP resultsSix Months Ended July 3, 2026 – Non-GAAP results
Net income69155531174821
Income tax expense(2)18991761222
Income before income taxes880647012351,043
Depreciation expense8383
Amortization of intangibles70-70
Interest expense, net124-5119
Adjusted EBITDA1,157641231,245
Adjusted EBITDA margin12.913.9%

Income Statement

Six Months Ended July 4, 2025

Six Months Ended July 4, 2025 – As reportedSix Months Ended July 4, 2025 – Acquisition, integration and restructuring costs(1)Six Months Ended July 4, 2025 – Amortization of acquired intangiblesSix Months Ended July 4, 2025 – Non-GAAP results
Operating income1,1017621,170
Non-operating expense, net-105-105
Income before income taxes9967621,065
Income tax expense(2)-238-2-15-255
Net income758547810
Less: net loss attributable to non-controlling interest44
Net income attributable to Leidos common stockholders754547806
Diluted EPS attributable to Leidos common stockholders(3)5.80.040.366.2
Diluted shares130130130130

Income Statement

Six Months Ended July 4, 2025

Six Months Ended July 4, 2025 – As reportedSix Months Ended July 4, 2025 – Acquisition, integration and restructuring costs(1)Six Months Ended July 4, 2025 – Amortization of acquired intangiblesSix Months Ended July 4, 2025 – Non-GAAP results
Net income758547810
Income tax expense(2)238215255
Income before income taxes9967621,065
Depreciation expense7979
Amortization of intangibles62-62
Interest expense, net104104
Adjusted EBITDA1,24171,248
Adjusted EBITDA margin14.614.7

Balance Sheet

July 3, 2026 — UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (in millions, except share and per share data)

July 3, 2026January 2, 2026
Cash and cash equivalents7481,108
Receivables, net2,9682,708
Inventory, net94342
Other current assets493656

Cash Flow

Three Months Ended — UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in millions)

Three Months Ended – July 3, 2026Three Months Ended – July 4, 2025Six Months Ended – July 3, 2026Six Months Ended – July 4, 2025
Net income356393691758
Adjustments to reconcile net income to net cash provided by operations:Depreciation and amortization8172153141
Adjustments to reconcile net income to net cash provided by operations:Stock-based compensation26255146
Adjustments to reconcile net income to net cash provided by operations:Deferred income taxes6224-2200
Adjustments to reconcile net income to net cash provided by operations:Net (gain) loss on pension plan settlement-320
Adjustments to reconcile net income to net cash provided by operations:Other4114
Change in assets and liabilities, net of effects of acquisitions and dispositions:Receivables-3310-193-236
Change in assets and liabilities, net of effects of acquisitions and dispositions:Other current assets and other long-term assets35-738-34
Change in assets and liabilities, net of effects of acquisitions and dispositions:Accounts payable and accrued liabilities and other long-term liabilities43-18897-260
Change in assets and liabilities, net of effects of acquisitions and dispositions:Accrued payroll and employee benefits188155347
Change in assets and liabilities, net of effects of acquisitions and dispositions:Income taxes receivable/payable90-199191-78
Change in assets and liabilities, net of effects of acquisitions and dispositions:Net cash provided by operating activities7934861,094544
Cash flows from investing activities:Acquisition of a business, net of cash acquired-285-2,338-285
Cash flows from investing activities:Payments for property, equipment and software-32-29-63-51
Cash flows from investing activities:Divestiture of a business4
Cash flows from investing activities:Net proceeds from sale of assets44
Cash flows from investing activities:Other-10-4
Cash flows from investing activities:Net cash used in investing activities-38-314-2,397-336
Cash flows from financing activities:Proceeds from debt issuance1,397997
Cash flows from financing activities:Repayments from commercial paper-300
Cash flows from financing activities:Repayments of borrowings-5-30-10-559
Cash flows from financing activities:Payments for debt issuance costs-15-7
Cash flows from financing activities:Dividend payments-55-52-110-105
Cash flows from financing activities:Repurchases of stock and other-72-9-315-537
Cash flows from financing activities:Proceeds from issuances of stock17163331
Cash flows from financing activities:Net capital distributions to non-controlling interests-1-2-3-7
Cash flows from financing activities:Other-7-6-7-6
Cash flows from financing activities:Net cash (used in) provided by financing activities-423-83970-193
Cash flows from financing activities:Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash1714

Cash Flow

Three Months Ended — UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [CONTINUED] (in millions)

Three Months Ended – July 3, 2026Three Months Ended – July 4, 2025Six Months Ended – July 3, 2026Six Months Ended – July 4, 2025
Net increase (decrease) in cash, cash equivalents and restricted cash, including cash classified in current assets held for sale33396-33329
Less: change in cash balances classified as assets held for sale4141
Net increase (decrease) in cash, cash equivalents and restricted cash29296-37429
Cash, cash equivalents and restricted cash at beginning of period5389241,204991
Cash, cash equivalents and restricted cash at end of period8301,0208301,020
Less: restricted cash at end of period82908290
Cash and cash equivalents at end of period748930748930

Cash Flow

Three Months Ended

Three Months Ended – July 3, 2026Three Months Ended – July 4, 2025
Net cash provided by operating activities793486
Payments for property, equipment and software-32-29
Non-GAAP free cash flow761457
Net income attributable to Leidos common stockholders354391
Acquisition, integration and restructuring costs(1)(2)261
Full release

FORWARD-LOOKING STATEMENTS

Certain statements in this release contain or are based on "forward-looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as "expects," "intends," "plans," "anticipates," "believes," "estimates," "guidance" and similar words or phrases. Forward-looking statements in this release include, among others, estimates of our future growth, strategy and financial and operating performance, including future revenues, adjusted EBITDA margins, diluted EPS (including on a non-GAAP basis) and cash flows provided by operating activities, as well as statements about our business contingency plans, government budgets and spending, uncertainties in tax due to new tax legislation or other regulatory developments, strategy, planned investments including the pending joint venture, sustainability goals and our future dividends, share repurchases, capital expenditures, debt repayments, acquisitions, dispositions and cash flow conversion. These statements reflect our belief and assumptions as to future events that may not prove to be accurate.

Actual performance and results may differ materially from those results anticipated by our guidance and other forward-looking statements made in this release depending on a variety of factors, including, but not limited to: developments in the U.S. government defense and non-defense budgets, including budget reductions, sequestration, implementation of spending limits or changes in budgetary priorities, potential future U.S. government shutdown and other or future delays in the U.S. government budget process, or the U.S. government’s failure to raise the debt ceiling, which increases the possibility of a default by the U.S. government on its debt obligations, related credit-rating downgrades, or an economic recession; uncertainties in tax due to new tax legislation or other regulatory developments; deterioration of economic conditions or weakening in credit or capital markets; uncertainty in the consequences of current and future geopolitical events; inflationary pressures and fluctuations in interest rates; delays in the U.S. government contract procurement process or the award of contracts and delays or loss of contracts as a result of competitor protests; changes in U.S. government procurement rules, regulations and practices; our compliance with various U.S. government and other government procurement rules and regulations; governmental reviews, audits and investigations of our company; our ability to effectively compete and win contracts with the U.S. government and other customers; our ability to respond rapidly to emerging technology trends, including the use of artificial intelligence; our reliance on information technology spending by hospitals/healthcare organizations; our reliance on infrastructure investments by industrial and natural resources organizations; energy efficiency and alternative energy sourcing investments; investments by U.S. government and commercial organizations in environmental impact and remediation projects; the effects of an epidemic, pandemic or similar outbreak may have on our business, financial position, results of operations and/or cash flows; our ability to attract, train and retain skilled employees, including our management team, and to obtain security clearances for our employees; our ability to accurately estimate costs, including cost increases due to inflation, associated with our firm-fixed-price contracts and other contracts; resolution of legal and other disputes with our customers and others or legal or regulatory compliance issues; cybersecurity, data security or other security threats, system failures or other disruptions of our business; our compliance with international, federal, state and local laws and regulations regarding privacy, data security, protection, storage, retention, transfer, disposal and other processing, technology protection and personal information; the damage and disruption to our business resulting from natural disasters and the effects of climate change; our ability to effectively acquire businesses and make investments; our ability to maintain relationships with prime contractors, subcontractors and joint venture partners; our ability to manage performance and other risks related to customer contracts; the failure of our inspection or detection systems to detect threats; the adequacy of our insurance programs, customer indemnifications or other liability protections designed to protect us from significant product or other liability claims, including cybersecurity attacks; our ability to manage risks associated with our international business; our ability to comply with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act of 2010 and similar worldwide anti-corruption and anti-bribery laws and regulations; our ability to protect our intellectual property and other proprietary rights by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to prevail in litigation brought by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to declare or increase future dividends based on our earnings, financial condition, capital requirements and other factors, including compliance with applicable law and our agreements; our ability to grow our commercial health and infrastructure businesses, which could be negatively affected by budgetary constraints faced by hospitals and by developers of energy and infrastructure projects; our ability to successfully integrate acquired businesses; and our ability to execute our business plan and long-term management initiatives effectively and to overcome these and other known and unknown risks that we face.

These are only some of the factors that may affect the forward-looking statements contained in this release. For further information concerning risks and uncertainties associated with our business, please refer to the filings we make from time to time with the U.S. Securities and Exchange Commission (SEC), including the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Legal Proceedings" sections of our latest Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, all of which may be viewed or obtained through the Investor Relations section of our website at www.leidos.com.

All information in this release is as of

August 4, 2026. Leidos expressly disclaims any duty to update the guidance or any other forward-looking statement provided in this release to reflect subsequent events, actual results or changes in Leidos' expectations. Leidos also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Leidos Holdings earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.